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participating, 1,219 were allocated to the minimum intervention and 1,682 to the extended intervention.
Study design
The study was a multi-centre randomised controlled trial. 49 participating practices were block randomised. Follow-up was assessed at 6 months and 1 year by questionnaire with an incentive and if deemed necessary, a telephone call. 69% of mothers completed both the 6 month and 12 month questionnaires, and therefore form the basis of the analysis. The proportions of mothers in both groups who completed both follow-up assessments were similar. However those who completed follow-ups in both groups tended to be quitters at enrolment, older, have higher educational levels, were white, had more than one child and were less likely to have husbands who smoked. Mothers in the extended intervention group who completed the follow-ups were more likely to be older, better educated and less likely to have husbands who smoked than the minimal intervention group. These confounding variables were adjusted for.
Analysis of effectiveness
The analysis of effectiveness was based on treatment completers only. The primary health outcomes used in the study were smoking quit rates, likelihood of trying to quit smoking, cigarettes smoked per day and prevention of relapse among quitters. Secondary outcome variables included readiness to quit, and attitude toward, and knowledge of, ETS
Effectiveness results
Among mothers who quit smoking for pregnancy, those who received the extended intervention were significantly more likely to maintain their cessation throughout the 12 month follow up period (32.8% versus 26.1%). Similarly, among mothers who smoked at enrolment, those who received the extended intervention were more likely to quit after 6 months and stay quit throughout the 12 month assessment period (2.3% versus 1.2%). However, when a logistic regression was estimated, controlling for age, education and husband/partner's smoking status at enrolment, the analysis demonstrated no effect of the extended intervention on sustained quitting for either smokers (5.5% versus 4.7%) or quitters (42.9% versus 39.1%). In analyses of secondary outcomes, the main effect of practice was not significant and was thus not reported. Among those mothers who were smokers at enrolment and continued smoking during the twelve month period, those in the extended intervention group smoked significantly fewer cigarettes per day (p<0.01), had a greater readiness to quit (p<0.001), and had a more negative attitude towards smoking (p<0.01) and a greater awareness of the dangers of passive smoke exposure (p<0.001). Among mothers who had quit at enrolment but had subsequently relapsed, participants in the extended intervention group reported a significantly higher likelihood of trying to quit again(P<0.01).
Clinical conclusions
A paediatric office-based intervention can have a significant impact on maternal smoking, but the effect decreases with time. At 6 months, the significant effect of reduced parental smoking, and the 6 month and relapse prevention outcomes, may provide some benefit, but at 12 months, there is a small and marginally non-significant intervention effect on cessation.
Modelling
None.
Measure of benefits used in the economic analysis
As the 12 month follow-up revealed no significant treatment effect of the extended intervention, a full economic analysis was not performed as it was considered not justifiable by the authors. However, cost data were collected and reported. materials. No dates were provided, quantities and costs were not analysed separately and only health service costs were considered. No information was provided on the methods of data collection. Further specific details are obtainable from the authors.
Statistical analysis of costs
Not performed.
Indirect Costs
Not included.
Currency

US dollars ($).
Sensitivity analysis
Estimated benefits used in the economic analysis
At 6 months, the significant effect of reduced parental smoking, and the 6 month and relapse prevention outcomes, may provide some benefit, but at 12 months, there is a small and marginally non-significant intervention effect on cessation. A full economic analysis was not performed because of the absence of an effect on the primary outcomes.
Cost results
For a practice with up to 4 paediatricians and 6 office staff, it was estimated that the fixed costs of implementing the extended intervention should be under $500 (with up to $200 budgeted for an outside facilitator). Staff costs to determine and record the smoking status of each new mother entering the programme would be about $0.20-0.75 per mother. Intervention costs for quitters and smokers (consisting of professional time, staff time and written materials) would total $10 to $15 per mother over 4 visits, with up to $10 more for smoking mothers needing assistance with giving up.
Synthesis of costs and benefits
Costs and benefits were not combined.
